FairScope Lab
EN 繁中 简中

BMY

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

8.89

PEG Ratio

0.10

Dividend Yield

-

Gross Margin

71.28%

Net Margin

25.57%

Revenue CAGR 3Y

4.94%

ROE

59.45%

ROA

15.14%

Buyback Yield

-0.22%

Current Ratio

1.53

Magic Earn Yield

11.78%

Altman Z-Score

1.86

Fair Value River

Score

Valuation 86
Profitability 71
Growth 16
Health 44
Yield 0
← Back to Dashboard